9-132264439-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_015046.7(SETX):​c.7834A>G​(p.Ser2612Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0525 in 1,609,902 control chromosomes in the GnomAD database, including 6,176 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.087 ( 1076 hom., cov: 31)
Exomes 𝑓: 0.049 ( 5100 hom. )

Consequence

SETX
NM_015046.7 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:15

Conservation

PhyloP100: -1.45

Publications

21 publications found
Variant links:
Genes affected
SETX (HGNC:445): (senataxin) This gene encodes a protein named for its homology to the Sen1p protein of fungi which has RNA helicase activity encoded by a domain at the C-terminal end of the protein. The protein encoded by this gene contains a DNA/RNA helicase domain at its C-terminal end which suggests that it may be involved in both DNA and RNA processing. Mutations in this gene have been associated with ataxia-ocular apraxia-2 (AOA2) and an autosomal dominant form of juvenile amyotrophic lateral sclerosis (ALS4). [provided by RefSeq, Jul 2008]
SETX Gene-Disease associations (from GenCC):
  • amyotrophic lateral sclerosis type 4
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
  • distal hereditary motor neuropathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.002356708).
BP6
Variant 9-132264439-T-C is Benign according to our data. Variant chr9-132264439-T-C is described in ClinVar as Benign. ClinVar VariationId is 195975.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.363 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SETXNM_015046.7 linkc.7834A>G p.Ser2612Gly missense_variant Exon 26 of 26 ENST00000224140.6 NP_055861.3 Q7Z333-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SETXENST00000224140.6 linkc.7834A>G p.Ser2612Gly missense_variant Exon 26 of 26 1 NM_015046.7 ENSP00000224140.5 Q7Z333-1
SETXENST00000436441.5 linkc.2647A>G p.Ser883Gly missense_variant Exon 17 of 17 5 ENSP00000409143.1 X6RI79
SETXENST00000477049.1 linkn.984A>G non_coding_transcript_exon_variant Exon 5 of 5 3

Frequencies

GnomAD3 genomes
AF:
0.0870
AC:
13180
AN:
151436
Hom.:
1070
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.164
Gnomad AMI
AF:
0.0308
Gnomad AMR
AF:
0.0740
Gnomad ASJ
AF:
0.0519
Gnomad EAS
AF:
0.377
Gnomad SAS
AF:
0.129
Gnomad FIN
AF:
0.0476
Gnomad MID
AF:
0.108
Gnomad NFE
AF:
0.0273
Gnomad OTH
AF:
0.0770
GnomAD2 exomes
AF:
0.0854
AC:
21453
AN:
251308
AF XY:
0.0811
show subpopulations
Gnomad AFR exome
AF:
0.166
Gnomad AMR exome
AF:
0.101
Gnomad ASJ exome
AF:
0.0483
Gnomad EAS exome
AF:
0.386
Gnomad FIN exome
AF:
0.0446
Gnomad NFE exome
AF:
0.0268
Gnomad OTH exome
AF:
0.0637
GnomAD4 exome
AF:
0.0489
AC:
71257
AN:
1458338
Hom.:
5100
Cov.:
30
AF XY:
0.0497
AC XY:
36087
AN XY:
725638
show subpopulations
African (AFR)
AF:
0.171
AC:
5698
AN:
33374
American (AMR)
AF:
0.0991
AC:
4425
AN:
44648
Ashkenazi Jewish (ASJ)
AF:
0.0488
AC:
1269
AN:
25982
East Asian (EAS)
AF:
0.394
AC:
15577
AN:
39564
South Asian (SAS)
AF:
0.105
AC:
9018
AN:
86236
European-Finnish (FIN)
AF:
0.0455
AC:
2398
AN:
52750
Middle Eastern (MID)
AF:
0.0826
AC:
474
AN:
5740
European-Non Finnish (NFE)
AF:
0.0253
AC:
28034
AN:
1109922
Other (OTH)
AF:
0.0726
AC:
4364
AN:
60122
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
4630
9260
13891
18521
23151
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1440
2880
4320
5760
7200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0872
AC:
13213
AN:
151564
Hom.:
1076
Cov.:
31
AF XY:
0.0905
AC XY:
6704
AN XY:
74092
show subpopulations
African (AFR)
AF:
0.164
AC:
6798
AN:
41350
American (AMR)
AF:
0.0747
AC:
1135
AN:
15196
Ashkenazi Jewish (ASJ)
AF:
0.0519
AC:
180
AN:
3470
East Asian (EAS)
AF:
0.377
AC:
1910
AN:
5072
South Asian (SAS)
AF:
0.129
AC:
607
AN:
4708
European-Finnish (FIN)
AF:
0.0476
AC:
503
AN:
10572
Middle Eastern (MID)
AF:
0.105
AC:
31
AN:
294
European-Non Finnish (NFE)
AF:
0.0273
AC:
1851
AN:
67882
Other (OTH)
AF:
0.0805
AC:
170
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
543
1087
1630
2174
2717
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
144
288
432
576
720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0518
Hom.:
2526
Bravo
AF:
0.0950
TwinsUK
AF:
0.0227
AC:
84
ALSPAC
AF:
0.0257
AC:
99
ESP6500AA
AF:
0.165
AC:
725
ESP6500EA
AF:
0.0260
AC:
224
ExAC
AF:
0.0851
AC:
10335
Asia WGS
AF:
0.253
AC:
878
AN:
3478
EpiCase
AF:
0.0308
EpiControl
AF:
0.0314

ClinVar

Significance: Benign
Submissions summary: Benign:15
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:7
Dec 17, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
Apr 12, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 20, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Amyotrophic lateral sclerosis type 4 Benign:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Feb 08, 2023
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 Benign:2
Feb 08, 2023
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2;C1865409:Amyotrophic lateral sclerosis type 4 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.061
BayesDel_addAF
Benign
-0.65
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
0.52
DANN
Benign
0.70
DEOGEN2
Benign
0.093
.;T
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.034
N
LIST_S2
Benign
0.55
T;T
MetaRNN
Benign
0.0024
T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
0.93
.;L
PhyloP100
-1.4
PrimateAI
Benign
0.24
T
PROVEAN
Benign
-0.33
N;N
REVEL
Benign
0.21
Sift
Benign
0.65
T;T
Sift4G
Benign
0.71
T;T
Polyphen
0.0
.;B
Vest4
0.0070
MPC
0.069
ClinPred
0.00059
T
GERP RS
-4.6
Varity_R
0.016
gMVP
0.12
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3739927; hg19: chr9-135139826; COSMIC: COSV107303869; API